US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
US4409229A
(en)
|
1977-12-02 |
1983-10-11 |
Hoechst-Roussel Pharmaceuticals, Inc. |
Antidepressive and tranquilizing substituted 1,3-dihydrospiro[benzo(c)thiophene]s
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
JPH0680054B2
(ja)
|
1985-06-19 |
1994-10-12 |
吉富製薬株式会社 |
ピペリジン誘導体
|
JPS6289679U
(es)
|
1985-11-22 |
1987-06-08 |
|
|
US4797419A
(en)
|
1986-11-03 |
1989-01-10 |
Warner-Lambert Company |
Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
DE3905364A1
(de)
|
1989-02-22 |
1990-08-23 |
Hoechst Ag |
Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
CA2064815C
(en)
|
1990-06-07 |
1999-11-16 |
Alan Duncan Robertson |
Therapeutic heterocyclic compounds
|
US5698155A
(en)
|
1991-05-31 |
1997-12-16 |
Gs Technologies, Inc. |
Method for the manufacture of pharmaceutical cellulose capsules
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
JP3191429B2
(ja)
|
1992-09-02 |
2001-07-23 |
富士通テン株式会社 |
電子機器の挿排装置
|
AU683620B2
(en)
|
1992-09-28 |
1997-11-20 |
Pfizer Inc. |
Substituted pyrimidines for control of diabetic complications
|
DE4234295A1
(de)
|
1992-10-12 |
1994-04-14 |
Thomae Gmbh Dr K |
Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
DE4302051A1
(de)
|
1993-01-26 |
1994-07-28 |
Thomae Gmbh Dr K |
5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
JP2606138Y2
(ja)
|
1993-04-20 |
2000-09-25 |
株式会社小松製作所 |
クラッチ作動圧力検出手段を備えたクラッチ油圧制御弁装置
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
DE19514313A1
(de)
|
1994-08-03 |
1996-02-08 |
Bayer Ag |
Benzoxazolyl- und Benzothiazolyloxazolidinone
|
DE69635048T2
(de)
|
1995-06-12 |
2006-02-16 |
G.D. Searle & Co. |
Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
|
CZ292327B6
(cs)
|
1995-09-07 |
2003-09-17 |
F. Hoffmann-La Roche Ag |
Derivát 4-(oxyalkoxyfenyl)-3-oxypiperidinu, způsob jeho přípravy, meziprodukt pro jeho přípravu a farmaceutický prostředek, který ho obsahuje
|
AU1117497A
(en)
|
1995-11-13 |
1997-06-05 |
Albany Medical College |
Analgesic compounds and uses thereof
|
FR2744448B1
(fr)
|
1996-02-02 |
1998-04-24 |
Pf Medicament |
Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
|
AU715202B2
(en)
|
1996-04-03 |
2000-01-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5891889A
(en)
|
1996-04-03 |
1999-04-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US5948786A
(en)
|
1996-04-12 |
1999-09-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
US5854245A
(en)
|
1996-06-28 |
1998-12-29 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
US5990107A
(en)
|
1996-06-28 |
1999-11-23 |
Merck & Co., Inc. |
Fibrinogen receptor antagonist prodrugs
|
US5798360A
(en)
|
1996-08-01 |
1998-08-25 |
Isis Pharmaceuticals, Inc. |
N-(aminoalkyl)- and/or N-(amidoalkyl)- dinitrogen heterocyclic compositions
|
FR2758328B1
(fr)
|
1997-01-15 |
1999-04-02 |
Pf Medicament |
Nouvelles amines aromatiques derivees d'amines cycliques utiles comme medicaments
|
FR2758327B1
(fr)
|
1997-01-15 |
1999-04-02 |
Pf Medicament |
Nouvelles arylpiperazines derivees de piperidine
|
WO1999009140A1
(en)
|
1997-08-20 |
1999-02-25 |
The Regents Of The University Of California |
Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
|
JPH11199573A
(ja)
|
1998-01-07 |
1999-07-27 |
Yamanouchi Pharmaceut Co Ltd |
5ht3受容体作動薬及び新規ベンゾチアゾール誘導体
|
EP1051176B1
(en)
|
1998-01-27 |
2006-11-22 |
Aventis Pharmaceuticals Inc. |
SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
|
EP0943683A1
(en)
|
1998-03-10 |
1999-09-22 |
Smithkline Beecham Plc |
Human vanilloid receptor homologue Vanilrep1
|
EP1087962A4
(en)
|
1998-06-19 |
2001-10-04 |
Lilly Co Eli |
PRODUCTION OF HETEROARYL COMPOUNDS
|
AU4395399A
(en)
|
1998-07-02 |
2000-01-24 |
Sankyo Company Limited |
Five-membered heteroaryl compounds
|
EP1122242B1
(en)
|
1998-09-22 |
2008-01-16 |
Astellas Pharma Inc. |
Cyanophenyl derivatives
|
AU3215500A
(en)
|
1999-01-25 |
2000-08-07 |
Smithkline Beecham Corporation |
Compounds and methods
|
GB9907097D0
(en)
|
1999-03-26 |
1999-05-19 |
Novartis Ag |
Organic compounds
|
KR20020005653A
(ko)
|
1999-04-01 |
2002-01-17 |
실버스타인 아써 에이. |
소르비톨 디하이드로게나제 저해제로서의 아미노피리미딘
|
EP1183238A1
(en)
|
1999-05-17 |
2002-03-06 |
Eli Lilly And Company |
Metabotropic glutamate receptor antagonists
|
GB9912411D0
(en)
|
1999-05-28 |
1999-07-28 |
Pfizer Ltd |
Compounds useful in therapy
|
DE19934799B4
(de)
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
WO2001017965A2
(en)
|
1999-09-07 |
2001-03-15 |
Syngenta Participations Ag |
Cyanopiperidines as pesticides
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
MXPA02007632A
(es)
|
2000-02-07 |
2004-08-23 |
Abbott Gmbh & Co Kg |
Derivados de 2-benzotiazolil urea y su uso como inhibidores de proteina cinasa.
|
ATE385794T1
(de)
|
2000-06-21 |
2008-03-15 |
Hoffmann La Roche |
Benzothiazolderivate zur behandlung von alzheimer und parkinson
|
AR028782A1
(es)
|
2000-07-05 |
2003-05-21 |
Taisho Pharmaceutical Co Ltd |
Derivados heterociclicos tetrahidropiridino o piperidino
|
ATE384036T1
(de)
|
2000-07-13 |
2008-02-15 |
Merck Patent Gmbh |
Chirale verbindungen i
|
KR20030024799A
(ko)
|
2000-07-20 |
2003-03-26 |
뉴로젠 코포레이션 |
캡사이신 수용체 리간드
|
IL154927A0
(en)
|
2000-10-18 |
2003-10-31 |
Pfizer Prod Inc |
Combination of statins and sorbitol dehydrogenase inhibitors
|
WO2002043762A2
(en)
|
2000-11-30 |
2002-06-06 |
Pfizer Products Inc. |
Combination of gaba agonists and sorbitol dehydrogenase inhibitors
|
US7193113B2
(en)
|
2000-12-15 |
2007-03-20 |
Japan Science And Technology Corporation |
Arylbis(perfluoroalkylsulfonyl) methane and metallic salt thereof, and methods for producing the same
|
US20030232996A1
(en)
|
2001-04-20 |
2003-12-18 |
Brown David L |
Regioselective synthesis of 3,4-di{(carboclyl or heterocyclyl)thiophenes
|
EP1408986B1
(en)
|
2001-05-08 |
2008-09-24 |
Yale University |
Proteomimetic compounds and methods
|
US20040038982A1
(en)
|
2001-07-13 |
2004-02-26 |
Bondinell William E. |
Compounds and methods
|
JP2003095951A
(ja)
|
2001-09-25 |
2003-04-03 |
Sumitomo Pharmaceut Co Ltd |
慢性関節リウマチ治療剤
|
JPWO2003029199A1
(ja)
|
2001-09-28 |
2005-01-13 |
武田薬品工業株式会社 |
ベンゼン誘導体、その製造法および用途
|
AU2002360621B2
(en)
|
2001-12-19 |
2007-01-25 |
Merck & Co., Inc. |
heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
|
US7390813B1
(en)
|
2001-12-21 |
2008-06-24 |
Xenon Pharmaceuticals Inc. |
Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
|
US20050119251A1
(en)
|
2001-12-21 |
2005-06-02 |
Jian-Min Fu |
Nicotinamide derivatives and their use as therapeutic agents
|
JP2003192673A
(ja)
|
2001-12-27 |
2003-07-09 |
Bayer Ag |
ピペラジンカルボキシアミド誘導体
|
ES2345044T3
(es)
|
2002-02-01 |
2010-09-14 |
Euro-Celtique S.A. |
2-piperazin-piridinas utiles para tratar el dolor.
|
ES2316777T3
(es)
|
2002-02-15 |
2009-04-16 |
Glaxo Group Limited |
Moduladores de receptores vainilloides.
|
US6974818B2
(en)
|
2002-03-01 |
2005-12-13 |
Euro-Celtique S.A. |
1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
|
EA007272B1
(ru)
|
2002-03-13 |
2006-08-25 |
Янссен Фармацевтика Н. В. |
Новые ингибиторы гистондеацетилазы
|
GB0209715D0
(en)
|
2002-04-27 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
CN1150176C
(zh)
|
2002-05-22 |
2004-05-19 |
上海医药工业研究院 |
芳烷酮哌嗪衍生物及其应用
|
WO2003099266A2
(en)
|
2002-05-23 |
2003-12-04 |
Abbott Laboratories |
Acetamides and benzamides that are useful in treating sexual dysfunction
|
TW200410688A
(en)
|
2002-06-26 |
2004-07-01 |
Ono Pharmaceutical Co |
Therapeutics for diseases from vasoconstriction or vasodilatation
|
WO2004002983A2
(en)
|
2002-06-28 |
2004-01-08 |
Euro-Celtique, S.A. |
Therapeutic piperazine derivatives useful for treating pain
|
EP1388538B1
(en)
|
2002-07-09 |
2010-09-01 |
Merck Patent GmbH |
Polymerisation Initiator
|
US7262194B2
(en)
|
2002-07-26 |
2007-08-28 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
WO2004010942A2
(en)
|
2002-07-31 |
2004-02-05 |
Smithkline Beecham Corporation |
Substituted heterocyclic compounds as modulators of the ccr5 receptor
|
US7157462B2
(en)
|
2002-09-24 |
2007-01-02 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
AU2003271064B2
(en)
|
2002-09-27 |
2010-06-17 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel adenine compound and use thereof
|
JP2006505570A
(ja)
|
2002-10-17 |
2006-02-16 |
アムジエン・インコーポレーテツド |
ベンズイミダゾール誘導体およびそれのバニロイド受容体リガンドとしての使用
|
US7582635B2
(en)
|
2002-12-24 |
2009-09-01 |
Purdue Pharma, L.P. |
Therapeutic agents useful for treating pain
|
EP1596869B1
(en)
|
2003-01-21 |
2014-06-04 |
New Form Pharmaceuticals Inc. |
Novel cocrystallization
|
US7223788B2
(en)
|
2003-02-14 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
|
DE10311065A1
(de)
|
2003-03-13 |
2004-09-23 |
Abbott Gmbh & Co. Kg |
Pyrimidin-2-on-Verbindungen und ihre therapeutische Verwendung
|
EP2281823A3
(en)
|
2003-05-20 |
2011-09-07 |
Ajinomoto Co., Inc. |
Anti-inflammatory and analgesic piperidine derivatives
|
MY142655A
(en)
|
2003-06-12 |
2010-12-15 |
Euro Celtique Sa |
Therapeutic agents useful for treating pain
|
US7129235B2
(en)
|
2003-07-11 |
2006-10-31 |
Abbott Laboratories |
Amides useful for treating pain
|
US20050009841A1
(en)
|
2003-07-11 |
2005-01-13 |
Zheng Guo Zhu |
Novel amides useful for treating pain
|
GEP20094676B
(en)
|
2003-07-24 |
2009-05-10 |
Euro Celtique Sa |
Piperidine compounds and pharmaceutical compositions containing them
|
PL1867644T3
(pl)
|
2003-07-24 |
2009-10-30 |
Euro Celtique Sa |
Związki heteroarylo-tetrahydropiperydylowe przydatne w leczeniu lub zapobieganiu bólu
|
EA009480B1
(ru)
|
2003-07-24 |
2008-02-28 |
Еуро-Селтик С. А. |
Гетероарил-тетрагидропиридины и их применение для лечения или профилактики боли
|
BRPI0413059A
(pt)
|
2003-07-29 |
2006-10-31 |
Xenon Pharmaceuticals Inc |
derivados de piridila e seu uso como agentes terapêuticos
|
SG145701A1
(en)
|
2003-07-30 |
2008-09-29 |
Xenon Pharmaceuticals Inc |
Piperazine derivatives and their use as therapeutic agents
|
US7514436B2
(en)
|
2003-07-30 |
2009-04-07 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
US7759348B2
(en)
|
2003-07-30 |
2010-07-20 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
US7335658B2
(en)
|
2003-07-30 |
2008-02-26 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
US7754711B2
(en)
|
2003-07-30 |
2010-07-13 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
US7605161B2
(en)
|
2003-07-30 |
2009-10-20 |
Xenon Pharmaceuticals Inc. |
Pyridyl derivatives and their use as therapeutic agents
|
DE602004025244D1
(de)
|
2003-08-01 |
2010-03-11 |
Euro Celtique Sa |
Zur behandlung von schmerzen geeignete therapeutische mittel
|
WO2005016910A1
(ja)
|
2003-08-18 |
2005-02-24 |
Sankio Chemical Co., Ltd. |
ピリジルテトラヒドロピリジン類およびピリジルピペリジン類とそれらの製造方法
|
DE602004017481D1
(de)
|
2003-09-22 |
2008-12-11 |
Euro Celtique Sa |
Zur behandlung von schmerzen geeignete therapeutische mittel
|
CN1856489A
(zh)
|
2003-09-22 |
2006-11-01 |
欧洲凯尔特公司 |
用于治疗疼痛的苯甲酰胺化合物
|
WO2005037284A1
(en)
|
2003-10-15 |
2005-04-28 |
Pfizer Products Inc. |
Sorbitol dehydrogenase inhibitor and hypertensive agent combinations
|
WO2005037845A1
(en)
|
2003-10-17 |
2005-04-28 |
Rigel Pharmaceuticals, Inc. |
Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors
|
RS50958B
(sr)
|
2003-12-30 |
2010-10-31 |
Euro-Celtique S.A. |
Piperazini korisni za lečenje bola
|
US7355045B2
(en)
|
2004-01-05 |
2008-04-08 |
Applera Corporation |
Isotopically enriched N-substituted piperazine acetic acids and methods for the preparation thereof
|
DE102004039789A1
(de)
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
AR051092A1
(es)
|
2004-09-20 |
2006-12-20 |
Xenon Pharmaceuticals Inc |
Derivados heterociclicos y su uso como inhibidores de la estearoil-coa
|
AU2005329423A1
(en)
|
2004-09-20 |
2006-09-28 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
JP5043668B2
(ja)
|
2004-09-20 |
2012-10-10 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
複素環誘導体および治療薬としてのそれらの使用
|
WO2006034446A2
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Pyridine derivatives for inhibiting human stearoyl-coa-desaturase
|
JP5265194B2
(ja)
*
|
2004-11-09 |
2013-08-14 |
チバ ホールディング インコーポレーテッド |
重合開始剤としてのn−置換イミド
|
US20060116368A1
(en)
|
2004-11-29 |
2006-06-01 |
Calvo Raul R |
4-Piperidinecarboxamide modulators of vanilloid VR1 receptor
|
GT200600046A
(es)
|
2005-02-09 |
2006-09-25 |
|
Terapia de combinacion
|
NZ561029A
(en)
|
2005-03-14 |
2011-03-31 |
High Point Pharmaceuticals Llc |
Benzazole dervatives, compositions, and method of use as beta-secretase inhibitors
|
DE102005014904A1
(de)
|
2005-03-26 |
2007-02-01 |
Abbott Gmbh & Co. Kg |
Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung
|
FR2884516B1
(fr)
|
2005-04-15 |
2007-06-22 |
Cerep Sa |
Antagonistes npy, preparation et utilisations
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
CA2621164A1
(en)
|
2005-08-26 |
2007-03-01 |
Shionogi & Co., Ltd. |
Derivative having ppar agonistic activity
|
RU2405770C2
(ru)
|
2005-09-27 |
2010-12-10 |
Сионоги Энд Ко., Лтд. |
Производное сульфонамида, обладающее антагонистической активностью в отношении рецептора pgd2
|
US20070155707A1
(en)
|
2005-12-29 |
2007-07-05 |
Kadmus Pharmaceuticals, Inc. |
Ionizable inhibitors of fatty acid amide hydrolase
|
ATE460404T1
(de)
|
2006-01-18 |
2010-03-15 |
Siena Biotech Spa |
Modulatoren von alpha7-nikotin-acetylcholin- rezeptoren und therapeutische anwendungen davon
|
CA2644069A1
(en)
|
2006-02-28 |
2007-09-07 |
Helicon Therapeutics, Inc. |
Therapeutic piperazines as pde4 inhibitors
|
WO2007103719A2
(en)
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
TW200815426A
(en)
|
2006-06-28 |
2008-04-01 |
Astrazeneca Ab |
New pyridine analogues II 333
|
WO2008005368A2
(en)
|
2006-06-30 |
2008-01-10 |
Abbott Laboratories |
Piperazines as p2x7 antagonists
|
WO2008013622A2
(en)
|
2006-07-27 |
2008-01-31 |
E. I. Du Pont De Nemours And Company |
Fungicidal azocyclic amides
|
EP2099755A2
(en)
|
2006-11-20 |
2009-09-16 |
Glenmark Pharmaceuticals S.A. |
Acetylene derivatives as stearoyl coa desaturase inhibitors
|
DE102006060598A1
(de)
|
2006-12-21 |
2008-06-26 |
Merck Patent Gmbh |
Tetrahydrobenzoisoxazole
|
JP2010523712A
(ja)
|
2007-04-13 |
2010-07-15 |
スーパージェン, インコーポレイテッド |
癌または過剰増殖の治療に有用なaxlキナーゼ阻害剤
|
CA2833209C
(en)
|
2007-04-27 |
2016-06-28 |
Purdue Pharma L.P. |
Piperidine and piperazine compounds as trpv1 antagonists
|
US8389549B2
(en)
|
2007-04-27 |
2013-03-05 |
Purdue Pharma L.P. |
Substituted pyridines useful for treating pain
|
WO2008147864A2
(en)
|
2007-05-22 |
2008-12-04 |
Xenon Pharmaceuticals Inc. |
Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
|
US8058299B2
(en)
|
2007-05-22 |
2011-11-15 |
Via Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
AU2008287542C1
(en)
|
2007-06-01 |
2015-01-22 |
The Trustees Of Princeton University |
Treatment of viral infections by modulation of host cell metabolic pathways
|
AU2008267026A1
(en)
|
2007-06-13 |
2008-12-24 |
Northeastern University |
Antibiotic compounds
|
EP2170845A1
(en)
|
2007-06-28 |
2010-04-07 |
Intervet International BV |
Substituted piperazines as cb1 antagonists
|
CN103497114A
(zh)
|
2007-06-29 |
2014-01-08 |
埃莫里大学 |
用于神经保护的nmda受体拮抗剂
|
JP2010533159A
(ja)
|
2007-07-09 |
2010-10-21 |
アストラゼネカ アクチボラグ |
化合物947
|
EP2185538A2
(en)
|
2007-08-09 |
2010-05-19 |
Abbott Laboratories |
Tetrahydropyridine carboxamide derivatives as trpvl antagonists
|
US7994174B2
(en)
|
2007-09-19 |
2011-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyridyl sulfonamides as modulators of ion channels
|
CA2700974A1
(en)
|
2007-10-04 |
2009-04-09 |
Merck Sharp & Dohme Corp. |
Substituted aryl sulfone derivatives as calcium channel blockers
|
JP2011506466A
(ja)
|
2007-12-11 |
2011-03-03 |
株式会社サイトパスファインダー |
カルボキサミド化合物ならびにケモカイン受容体アゴニストとしてのそれらの使用
|
US7935817B2
(en)
|
2008-03-31 |
2011-05-03 |
Apotex Pharmachem Inc. |
Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
|
JP2009249346A
(ja)
|
2008-04-08 |
2009-10-29 |
Fujifilm Corp |
ピリジン骨格を有する血液脳関門透過性化合物
|
WO2009155116A2
(en)
|
2008-05-30 |
2009-12-23 |
Georgetown University |
Methods of reducing pain and inflammation
|
RU2500678C2
(ru)
|
2008-07-21 |
2013-12-10 |
Пэдью Фарма Л.П. |
Замещенные хиноксалинового типа мостиковые пиперидиновые соединения и их применение
|
US8703962B2
(en)
|
2008-10-24 |
2014-04-22 |
Purdue Pharma L.P. |
Monocyclic compounds and their use as TRPV1 ligands
|
US8546388B2
(en)
|
2008-10-24 |
2013-10-01 |
Purdue Pharma L.P. |
Heterocyclic TRPV1 receptor ligands
|
US8759362B2
(en)
|
2008-10-24 |
2014-06-24 |
Purdue Pharma L.P. |
Bicycloheteroaryl compounds and their use as TRPV1 ligands
|
WO2010114957A1
(en)
|
2009-04-03 |
2010-10-07 |
Schering Corporation |
Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
|
EP2576539B1
(de)
|
2010-05-27 |
2017-12-13 |
Bayer CropScience AG |
Pyridinylcarbonsäure derivate als fungizide
|
US8921373B2
(en)
|
2010-06-22 |
2014-12-30 |
Shionogi & Co., Ltd. |
Compounds having TRPV1 antagonistic activity and uses thereof
|
WO2012047764A1
(en)
|
2010-10-04 |
2012-04-12 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
ES2543151T3
(es)
|
2010-10-20 |
2015-08-17 |
Pfizer Inc |
Derivados de 2-piridina como moduladores del receptor Smoothened
|
CN103189371B
(zh)
|
2010-11-04 |
2015-04-01 |
施万生物制药研发Ip有限责任公司 |
丙型肝炎病毒抑制剂
|
US8546443B2
(en)
|
2010-12-21 |
2013-10-01 |
Boehringer Ingelheim International Gmbh |
Benzylic oxindole pyrimidines
|
US20120202794A1
(en)
|
2011-01-24 |
2012-08-09 |
Pharmasset, Inc. |
Compounds
|
WO2012117421A1
(en)
|
2011-03-02 |
2012-09-07 |
Orchid Research Laboratories Ltd |
Histone deacetylase inhibitors
|
CN102336720B
(zh)
|
2011-03-02 |
2016-01-13 |
华中科技大学 |
2-氨基噻唑衍生物及制备方法和应用
|
WO2012158784A2
(en)
|
2011-05-16 |
2012-11-22 |
Theodore Mark Kamenecka |
Modulators of the nuclear hormone receptor ror
|
WO2012158844A1
(en)
|
2011-05-17 |
2012-11-22 |
Shionogi & Co., Ltd. |
Heterocyclic compounds
|
AR086709A1
(es)
|
2011-06-22 |
2014-01-15 |
Purdue Pharma Lp |
Antagonistas trpv1 que incluyen sustituyentes dihidroxi y sus usos
|
WO2013019621A1
(en)
|
2011-07-29 |
2013-02-07 |
Tempero Pharmaceuticals, Inc. |
Compounds and methods
|
US9394293B2
(en)
|
2011-08-10 |
2016-07-19 |
Purdue Pharma L.P. |
TRPV1 antagonists including dihydroxy substituent and uses thereof
|
WO2013066831A1
(en)
|
2011-10-31 |
2013-05-10 |
Glaxosmithkline Llc |
Compounds and methods
|
US8426450B1
(en)
|
2011-11-29 |
2013-04-23 |
Helsinn Healthcare Sa |
Substituted 4-phenyl pyridines having anti-emetic effect
|
CN104470903B
(zh)
|
2012-01-25 |
2017-02-22 |
诺华股份有限公司 |
杂环化合物和它们的使用方法
|
WO2013142628A2
(en)
|
2012-03-20 |
2013-09-26 |
Fred Hutchinson Cancer Research Center |
Antibiotic compounds and compositions, and methods for identification thereof
|
WO2013153539A1
(en)
|
2012-04-13 |
2013-10-17 |
Glenmark Pharmaceuticals S.A. |
Tricyclic compounds as tec kinase inhibitors
|
EP2852585A1
(en)
|
2012-05-11 |
2015-04-01 |
AbbVie Inc. |
Nampt inhibitors
|
GB201212513D0
(en)
|
2012-07-13 |
2012-08-29 |
Ucb Pharma Sa |
Therapeutic agents
|